CA3225639A1 - Systeme de reacteur et ses procedes d'utilisation - Google Patents
Systeme de reacteur et ses procedes d'utilisation Download PDFInfo
- Publication number
- CA3225639A1 CA3225639A1 CA3225639A CA3225639A CA3225639A1 CA 3225639 A1 CA3225639 A1 CA 3225639A1 CA 3225639 A CA3225639 A CA 3225639A CA 3225639 A CA3225639 A CA 3225639A CA 3225639 A1 CA3225639 A1 CA 3225639A1
- Authority
- CA
- Canada
- Prior art keywords
- chamber
- chambers
- minutes
- cartridge
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/48—Automatic or computerized control
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/42—Integrated assemblies, e.g. cassettes or cartridges
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M27/00—Means for mixing, agitating or circulating fluids in the vessel
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M33/00—Means for introduction, transport, positioning, extraction, harvesting, peeling or sampling of biological material in or from the apparatus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Computer Hardware Design (AREA)
- Clinical Laboratory Science (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
L'invention concerne des systèmes, des procédés et des dispositifs pour la production et le traitement en continu de composés, y compris de composés biopharmaceutiques. Le système et les dispositifs sont actionnés de manière automatisée et peuvent fonctionner dans des conditions conformes aux bonnes pratiques de fabrication (BPF).
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163217680P | 2021-07-01 | 2021-07-01 | |
| US63/217,680 | 2021-07-01 | ||
| BE20215657A BE1029694B1 (fr) | 2021-08-18 | 2021-08-18 | Système de réacteur et méthodes pour l'utilisation de celui-ci |
| BE2021/5657 | 2021-08-18 | ||
| US202263331568P | 2022-04-15 | 2022-04-15 | |
| US63/331,568 | 2022-04-15 | ||
| US17/854,536 US20230011323A1 (en) | 2021-07-01 | 2022-06-30 | Reactor system and methods for using thereof |
| US17/854,536 | 2022-06-30 | ||
| PCT/EP2022/068259 WO2023275355A1 (fr) | 2021-07-01 | 2022-07-01 | Système de réacteur et ses procédés d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3225639A1 true CA3225639A1 (fr) | 2023-01-05 |
Family
ID=82214440
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3225639A Pending CA3225639A1 (fr) | 2021-07-01 | 2022-07-01 | Systeme de reacteur et ses procedes d'utilisation |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4363551A1 (fr) |
| JP (1) | JP2024526249A (fr) |
| KR (1) | KR20240029771A (fr) |
| AU (1) | AU2022301719A1 (fr) |
| CA (1) | CA3225639A1 (fr) |
| IL (1) | IL309834A (fr) |
| TW (1) | TW202321432A (fr) |
| WO (1) | WO2023275355A1 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106776A1 (fr) * | 2023-11-17 | 2025-05-22 | Amgen Inc. | Systèmes et procédés d'évaluation améliorée de molécules |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI885664B (zh) * | 2023-12-27 | 2025-06-01 | 南亞塑膠工業股份有限公司 | 細胞培養袋 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018031769A1 (fr) * | 2016-08-10 | 2018-02-15 | Lonza Inc. | Examen de recettes de lots biopharmaceutiques par exception |
| EP3714035A4 (fr) * | 2017-11-22 | 2021-08-18 | Culture Biosciences, Inc. | Cellule de travail d'automatisation de fermentation |
| US10689669B1 (en) * | 2020-01-11 | 2020-06-23 | Inscripta, Inc. | Automated multi-module cell processing methods, instruments, and systems |
-
2022
- 2022-07-01 KR KR1020247003557A patent/KR20240029771A/ko active Pending
- 2022-07-01 AU AU2022301719A patent/AU2022301719A1/en active Pending
- 2022-07-01 TW TW111124852A patent/TW202321432A/zh unknown
- 2022-07-01 IL IL309834A patent/IL309834A/en unknown
- 2022-07-01 CA CA3225639A patent/CA3225639A1/fr active Pending
- 2022-07-01 EP EP22733683.1A patent/EP4363551A1/fr active Pending
- 2022-07-01 JP JP2023580531A patent/JP2024526249A/ja active Pending
- 2022-07-01 WO PCT/EP2022/068259 patent/WO2023275355A1/fr not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025106776A1 (fr) * | 2023-11-17 | 2025-05-22 | Amgen Inc. | Systèmes et procédés d'évaluation améliorée de molécules |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023275355A1 (fr) | 2023-01-05 |
| AU2022301719A1 (en) | 2024-02-15 |
| TW202321432A (zh) | 2023-06-01 |
| EP4363551A1 (fr) | 2024-05-08 |
| IL309834A (en) | 2024-02-01 |
| JP2024526249A (ja) | 2024-07-17 |
| KR20240029771A (ko) | 2024-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230011323A1 (en) | Reactor system and methods for using thereof | |
| CN112334579B (zh) | 用于rna体外转录的生物反应器 | |
| Perry et al. | Lentiviral vector bioprocessing | |
| Lin et al. | Digital loop-mediated isothermal amplification on a commercial membrane | |
| Xie et al. | Engineering SARS-CoV-2 using a reverse genetic system | |
| Duarte et al. | Bacterial microcolonies in gel beads for high-throughput screening of libraries in synthetic biology | |
| CA3225639A1 (fr) | Systeme de reacteur et ses procedes d'utilisation | |
| Thomassen et al. | Scale‐down of the inactivated polio vaccine production process | |
| Gränicher et al. | Production of modified Vaccinia Ankara virus by intensified cell cultures: a comparison of platform technologies for viral vector production | |
| JP7721453B2 (ja) | マルチパラレルバイオリアクター中で接着性細胞を培養するための方法 | |
| Kaiser et al. | Single-use bioreactors for animal and human cells | |
| Sloth et al. | Analysis of compositional bias in a commercial phage display peptide library by next-generation sequencing | |
| Srinivasan et al. | Circular RNA formation and degradation are not directed by universal pathways | |
| Vitalis et al. | Leveraging interactions in microfluidic droplets for enhanced biotechnology screens | |
| Ladd et al. | Proof-of-concept of continuous transfection for adeno-associated virus production in microcarrier-based culture | |
| Yang et al. | Development of an integrated continuous manufacturing process for the rVSV-vectored SARS-CoV-2 candidate vaccine | |
| Chaves et al. | Evaluation of commercial RNA extraction protocols for avian influenza virus using nanopore metagenomic sequencing | |
| Wang et al. | Detection of porcine circovirus (PCV) using CRISPR-Cas12a/13a coupled with isothermal amplification | |
| Podgornik et al. | Continuous production of bacteriophages | |
| CN117795054A (zh) | 反应器系统及其使用方法 | |
| BE1029694B1 (fr) | Système de réacteur et méthodes pour l'utilisation de celui-ci | |
| Pang et al. | Evaluation of the Robustness Verification of Downstream Production Process for Inactivated SARS-CoV-2 Vaccine and Different Chromatography Medium Purification Effects | |
| WO2024141622A1 (fr) | Procédé et dispositif de mise en œuvre en continu d'une réaction biochimique liquide | |
| Kang et al. | Accurate diagnosis of COVID-19 from self-collectable biospecimens using synthetic apolipoprotein H peptide-coated nanoparticle assay | |
| Patel et al. | Developing an effective scale-down model for a suspension adapted HEK293T-derived lentiviral vector stable producer cell line |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20251231 |